Finally NGL has received EU approval for Triclabendazole after a long wait (link). They have approved capacity of 2000 KG/Month.
Overall, number of EDQM review closures has increased meaningfully since Jan’24. With that, one can expect outcome on other two filings (Flunixin Meglumine and Marbofloxacin) for EU in a reasonable timeframe. Augers well to get started in regulated EU market.
Thanks,
Tarun
Disc: Holding (no transactions in 60+ days)
| Subscribe To Our Free Newsletter |
